Blue Sky Laser & Tox Introduces XERF Skin Tightening and becoming the first provider in Arlington, Virginia

Blue Sky Laser & Tox has become Arlington, Virginia's first provider of XERF, a Korean-developed dual-frequency radiofrequency platform for nonsurgical skin tightening. The launch expands the practice's energy-based treatment menu and reflects growing patient demand for collagen remodeling without surgery.

Arlington, Virginia, United States, October 22, 2026 -- The market for nonsurgical aesthetic procedures continues to expand as patients prioritize visible improvements without invasive surgery, injections, or extended downtime. Data from the International Society of Aesthetic Plastic Surgery shows that nearly 17.3 million nonsurgical procedures were performed globally in 2025. This number reflects strong, ongoing interest in minimally invasive care.

Addressing skin laxity remains a complex challenge in aesthetic medicine. Collagen production, skin firmness, texture, and tone change at different rates across the face and body. Patients also bring diverse expectations regarding the timeline for visible results. These variables underscore the importance of thorough patient education and customized treatment planning.

To meet this demand, Blue Sky Laser & Tox has introduced XERF skin tightening at its Arlington, Virginia location. The practice began offering the technology in July 2026 and states it is the first Arlington provider to add the Korean-developed platform to its treatment menu.

XERF utilizes multifrequency monopolar radiofrequency energy, combining 6.78 MHz and 2 MHz frequencies in a single session. This combination targets both superficial and deeper layers of tissue, delivering controlled thermal energy at different tissue depths, with the goal of improving firmness through collagen remodeling over time. Results vary. XERF initially launched in South Korea in 2024 and received FDA clearance for the U.S. market on August 11, 2025, per the FDA.

The launch brings a treatment associated with South Korean aesthetic technology to patients in Arlington and the broader Washington, DC, Maryland, and Virginia region. The practice positions XERF as part of a comprehensive approach to skin quality. Rather than treating firmness as an isolated concern, providers may evaluate texture, tone, skincare, and the patient's goals when developing a plan. The practice also offers other energy-based treatments, injectables, skincare services, and skin analysis options across a menu of 27 high-quality, high-tech treatments.

Jing, NP, founder, medical director and lead injector, is a board-certified nurse practitioner with advanced training that includes study in South Korea. Her professional background includes acute care medicine and transplant surgery. She has contributed expert commentary to Medspa California and is bylined in Essence & Style on nonsurgical skin tightening. The practice's clinical team brings more than 30 years of combined experience.

Patient education remains a focus of the XERF launch. During a consultation, providers can discuss the treatment process, expected changes, possible limitations, and whether the technology suits the patient's concerns. Results can vary, and treatment plans depend on individual skin characteristics and clinical assessment.

The introduction of XERF gives patients in the DMV region another nonsurgical option for addressing skin laxity. It also reflects Blue Sky Laser & Tox's stated focus on combining technology with individualized skin care and realistic expectations.

About the company: Since opening, Blue Sky Laser & Tox has treated more than 5,000 patients and maintains a 5-star rating across hundreds of client reviews. It serves patients throughout Washington, DC, Maryland, and Virginia. Under the direction of Jing Castro, NP, the practice provides injectables, laser treatments, skin tightening, skincare, and wellness services.

Contact Info:
Name: Jing Castro
Email: Send Email
Organization: Blue Sky Laser & Tox
Website: http://www.blueskylasertox.com

Release ID: 89205936

If there are any deficiencies, discrepancies, or concerns regarding the information presented in this press release, we kindly request that you promptly inform us by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team is committed to addressing any identified issues within 8 hours to guarantee the delivery of accurate and reliable content to our esteemed readers.